Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.11 USD
0.69%
Market Closed
Updated:
Apr 29, 2024
Amphastar Pharmaceuticals Inc
Net Income (Common)
|
Amphastar Pharmaceuticals Inc
Net Income (Common) Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Net Income (Common)
$137.5m
|
CAGR 3-Years
361%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$40.6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
$8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
$2.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-21%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$365m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-22%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
See Also
What is Amphastar Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
137.5m
USD
137.5m
USD
Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Net Income (Common) amounts to 137.5m USD.
What is Amphastar Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
28%
28%
Over the last year, the Net Income (Common) growth was 50%. The average annual Net Income (Common) growth rates for Amphastar Pharmaceuticals Inc have been 361% over the past three years , and 28% over the past ten years .
You don't have any saved screeners yet
